Internal Medicine, Hematology & Oncology · Bend, OR
NPI
1164532107
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2500 NE Neff Rd
Bend, OR, 97701
Phone (541) 382-4321
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
2,135 services
Medicare patients, 2024
406
Average age 75
Drug cost, 2024
$6.7M
2,410 prescriptions
Company payments, 2023
$47.33
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd Clover was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 867 times for 343 patients. In total Todd Clover billed 2,135 services in 20 codes, and Medicare paid $107K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 867 | 343 | $12.26 | $11K |
| 99214 Office E&M - Established | Facility | 724 | 313 | $67.10 | $49K |
| 99215 Office E&M - Established | Facility | 191 | 116 | $104.33 | $20K |
| 99205 Office E&M - New | Facility | 63 | 63 | $133.49 | $8,410 |
| 99232 Hospital E&M - Subsequent | Facility | 61 | 21 | $58.59 | $3,574 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 32 | $12.97 | $675 |
| 99214 Office E&M - Established | Office | 39 | 25 | $76.27 | $2,974 |
| 99204 Office E&M - New | Facility | 30 | 30 | $85.22 | $2,557 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 13 | $92.49 | $2,035 |
| 99215 Office E&M - Established | Office | 17 | 13 | $116.72 | $1,984 |
| 99223 Hospital E&M - Initial | Facility | 12 | 11 | $132.17 | $1,586 |
By year: 2022 $99K for 1,225 services; 2023 $89K for 1,104 services; 2024 $107K for 2,135 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd Clover prescribed most often to Medicare patients was Prednisone, with 184 prescriptions and refills. In total Todd Clover wrote 2,410 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 184 | 212 | 39 | $726 |
| Abiraterone Acetate Generic | 139 | 159 | 16 | $12K |
| Letrozole Generic | 115 | 207 | 22 | $1,523 |
| Ondansetron Hcl Generic | 103 | 105 | 50 | $862 |
| Levothyroxine Sodium Generic | 92 | 131 | 13 | $661 |
| Prochlorperazine Maleate Generic | 91 | 91 | 54 | $599 |
| Eliquis Apixaban | 70 | 96 | 15 | $55K |
| Calquence Acalabrutinib Maleate | 70 | 70 | Under 11 | $1.0M |
| Hydroxyurea Generic | 70 | 116 | 14 | $1,663 |
| Dexamethasone Generic | 68 | 70 | 33 | $643 |
| Potassium Chloride Generic | 64 | 91 | 13 | $1,182 |
| Gabapentin Generic | 59 | 79 | 14 | $777 |
| Lorazepam Generic | 57 | 58 | 21 | $150 |
| Tamoxifen Citrate Generic | 51 | 101 | 14 | $2,258 |
| Trazodone Hcl Generic | 51 | 51 | 13 | $224 |
Brand drugs: 560 claims; generic drugs: 1,850 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Todd Clover $47.33 ($47.33 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novocure Inc. with $25.52.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.